EV/EBITDA
0.59
+0.06+11.32%
119 min ago
Summary
- As of February 7, 2025, CNTX EV/EBITDA is 0.59, with a rise of +0.06 (+11.32%) during the most recent trading day.
- Over the past year, CNTX EV/EBITDA has increased by +0.67 (+837.50%).
- CNTX EV/EBITDA is now -72.43% below its all-time high of 2.14.
Performance
CNTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CNTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +11.3% | -9.9% | -2.6% |
| 1 m1 month | +555.6% | -578.8% | -19.9% |
| 3 m3 months | +126.6% | -126.4% | -58.2% |
| 6 m6 months | +116.1% | -126.0% | -62.5% |
| ytdytd | +227.8% | -228.3% | -16.8% |
| 1 y1 year | +837.5% | -1055.7% | -15.2% |
| 5 y5 years | - | - | - |
CNTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.2% | -0.14 | +521.4% | |
| 3 m | 3-month | 0.73 | -19.2% | -2.22 | +126.6% |
| 6 m | 6-month | 0.73 | -19.2% | -4.89 | +112.1% |
| 1 y | 1-year | 0.73 | -19.2% | -6.97 | +108.5% |
| 3 y | 3-year | 2.14 | -72.4% | -6.97 | +108.5% |
| 5 y | 5-year | 2.14 | -72.4% | -19.76 | +103.0% |
| alltime | all time | 2.14 | -72.4% | -19.76 | +103.0% |
Context Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 0.59(+227.8%) |
| 2024 | 0.18(-228.6%) |
| Date | Value |
|---|---|
| 2023 | -0.14(-108.2%) |
| 2022 | 1.70(+146.4%) |
| 2021 | 0.69 |
FAQ
- What is Context Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Context Therapeutics?
- What is CNTX EV/EBITDA year-to-date change?
- What is Context Therapeutics EV/EBITDA year-on-year change?
What is Context Therapeutics EV/EBITDA?
The current EV/EBITDA of CNTX is 0.59
What is the all time high EV/EBITDA for Context Therapeutics?
Context Therapeutics all-time high EV/EBITDA is 2.14
What is CNTX EV/EBITDA year-to-date change?
Context Therapeutics EV/EBITDA has changed by +0.41 (+227.78%) since the beginning of the year
What is Context Therapeutics EV/EBITDA year-on-year change?
Over the past year, CNTX EV/EBITDA has changed by +0.67 (+837.50%)